Scotts Miracle-Gro (SMG) Financials

$61.01 +1.18 (+1.97%)

Closing price 03:59 PM Eastern

Extended Trading

$61.44 +0.44 (+0.71%)

As of 05:14 PM Eastern

Annual Income Statements for Scotts Miracle-Gro

This table shows Scotts Miracle-Gro's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015
Net Income / (Loss) Attributable to Common Shareholders	-35	-380	-438	513	387	461	64	218	315	160
Consolidated Net Income / (Loss)	-35	-380	-438	513	389	460	64	219	315	159
Net Income / (Loss) Continuing Operations	-35	-380	-438	517	387	437	128	198	246	129
Total Pre-Tax Income	-24	-453	-558	677	511	582	116	315	384	205
Total Operating Income	209	-174	-434	723	585	410	199	433	448	254
Total Gross Profit	851	657	873	1,469	1,347	1,020	865	973	900	811
Total Revenue	3,553	3,551	3,924	4,925	4,132	3,156	2,663	2,642	2,506	2,371
Operating Revenue	3,553	3,551	3,924	4,925	4,132	3,156	2,663	2,642	2,506	2,371
Total Cost of Revenue	2,702	2,894	3,051	3,456	2,785	2,136	1,799	1,670	1,606	1,560
Operating Cost of Revenue	2,619	2,708	2,891	3,431	2,769	2,131	1,778	1,670	1,600	1,557
Other Cost of Revenue	84	186	160	25	16	5.90	21	0.00	5.90	3.00
Total Operating Expenses	642	832	1,307	746	762	610	666	539	453	557
Selling, General & Admin Expense	559	551	613	744	758	601	540	551	518	489
Other Operating Expenses / (Income)	20	-0.10	0.80	-1.80	3.20	1.30	-6.70	-17	-14	-2.20
Restructuring Charge	63	281	693	4.30	0.80	7.40	132	4.90	-52	70
Total Other Income / (Expense), net	-232	-279	-124	-46	-75	172	-83	-119	-64	-49
Interest Expense	159	178	118	79	95	102	86	76	72	49
Interest & Investment Income	-68	-101	-13	14	0.00	3.30	4.90	-29	7.80	0.00
Other Income / (Expense), net	-5.50	0.30	6.90	19	20	271	-1.70	-13	0.00	0.00
Income Tax Expense	11	-73	-121	160	124	145	-12	117	138	76
Basic Earnings per Share	($0.61)	($6.79)	($7.88)	$9.20	$6.96	$8.30	$1.13	$3.68	$5.16	$2.62
Weighted Average Basic Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	56.20M	59.40M	61.10M	61.10M
Diluted Earnings per Share	($0.61)	($6.79)	($7.88)	$8.96	$6.81	$8.18	$1.12	$3.63	$5.09	$2.57
Weighted Average Diluted Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	56.20M	59.40M	61.10M	61.10M
Weighted Average Basic & Diluted Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	56.20M	59.40M	61.10M	61.10M
Cash Dividends to Common per Share	$2.64	$2.64	$2.64	$2.52	$7.36	$2.23	$2.14	$2.03	$1.91	$1.82

This table shows Scotts Miracle-Gro's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/30/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	218	-70	-244	132	158	-81	-469	44	109	-65	-220
Consolidated Net Income / (Loss)	218	-70	-244	132	158	-81	-469	44	109	-65	-220
Net Income / (Loss) Continuing Operations	218	-70	-244	132	158	-81	-469	44	109	-65	-220
Total Pre-Tax Income	301	-96	-312	183	220	-114	-561	52	150	-94	-272
Total Operating Income	345	-51	-216	200	272	-47	-416	77	206	-42	-224
Total Gross Profit	548	95	-30	354	464	62	-57	206	413	96	-71
Total Revenue	1,421	417	415	1,202	1,525	410	375	1,119	1,532	527	494
Operating Revenue	1,421	417	415	1,202	1,525	410	375	1,119	1,532	527	494
Total Cost of Revenue	873	322	444	848	1,062	348	432	913	1,119	431	564
Operating Cost of Revenue	866	317	427	851	987	354	408	880	1,000	421	475
Other Cost of Revenue	7.30	5.10	17	-2.50	75	-5.80	24	33	119	10	89
Total Operating Expenses	203	146	187	154	192	110	359	129	207	138	153
Selling, General & Admin Expense	188	125	118	148	179	115	108	129	186	129	118
Other Operating Expenses / (Income)	4.20	4.50	0.40	6.90	11	1.80	2.60	-1.60	-1.60	0.50	2.00
Restructuring Charge	11	17	69	-0.80	2.10	-7.10	249	1.70	22	8.50	33
Total Other Income / (Expense), net	-44	-45	-96	-17	-52	-67	-145	-25	-56	-53	-48
Interest Expense	37	34	33	39	44	43	40	47	48	43	35
Interest & Investment Income	-5.90	-9.90	-62	23	-7.00	-23	-105	22	-7.30	-11	-14
Other Income / (Expense), net	-1.30	-1.30	-1.40	-1.30	-1.20	-1.60	-0.10	-0.40	-0.80	1.60	1.50
Income Tax Expense	83	-26	-68	51	62	-34	-92	8.30	40	-30	-52
Basic Earnings per Share	$3.78	($1.21)	($4.29)	$2.33	$2.77	($1.42)	($8.35)	$0.78	$1.95	($1.17)	($3.95)
Weighted Average Basic Shares Outstanding	57.60M	57.30M	57.41M	56.80M	56.80M	56.70M	56.55M	56.20M	56M	55.50M	55.46M
Diluted Earnings per Share	$3.72	($1.21)	($4.21)	$2.28	$2.74	($1.42)	($8.33)	$0.77	$1.94	($1.17)	($3.91)
Weighted Average Diluted Shares Outstanding	58.40M	57.30M	57.41M	58M	57.40M	56.70M	56.55M	56.60M	56.50M	55.50M	55.46M
Weighted Average Basic & Diluted Shares Outstanding	57.72M	57.47M	57.41M	56.82M	56.80M	56.69M	56.55M	56.16M	56.07M	55.96M	55.46M
Cash Dividends to Common per Share	$0.66	$0.66	-	$0.66	-	$0.66	-	$0.66	$0.66	$0.66	-

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015
Net Change in Cash & Equivalents	40	-55	-157	228	-2.20	-15	-87	70	-21	-18
Net Cash From Operating Activities	668	531	-129	272	558	227	343	363	244	247
Net Cash From Continuing Operating Activities	668	531	-129	272	558	227	343	363	244	247
Net Income / (Loss) Continuing Operations	-35	-380	-438	513	389	460	64	219	315	159
Consolidated Net Income / (Loss)	-35	-380	-438	513	389	460	64	219	315	159
Depreciation Expense	65	67	68	63	62	56	53	55	54	51
Amortization Expense	16	25	37	31	33	33	30	25	20	18
Non-Cash Adjustments To Reconcile Net Income	233	459	714	38	73	-224	169	24	-114	18
Changes in Operating Assets and Liabilities, net	389	360	-511	-374	1.70	-99	27	40	-30	1.70
Net Cash From Investing Activities	-100	-66	-283	-539	47	255	-581	22	-134	-536
Net Cash From Continuing Investing Activities	-100	-66	-283	-539	47	255	-581	22	-134	-536
Purchase of Property, Plant & Equipment	-84	-93	-114	-107	-63	-42	-68	-70	-58	-62
Acquisitions	-21	0.00	-237	-128	0.00	-6.60	-528	-122	-183	-480
Purchase of Investments	0.00	0.00	-25	-295	-3.40	0.00	-	-	-	0.00
Sale of Property, Plant & Equipment	2.40	2.50	63	0.20	116	2.10	5.10	5.70	2.40	5.50
Other Investing Activities, net	2.60	25	29	-8.70	-2.90	7.00	11	-30	-90	0.00
Net Cash From Financing Activities	-528	-520	255	494	-607	-497	151	-317	-129	279
Net Cash From Continuing Financing Activities	-528	-520	255	494	-607	-497	151	-317	-129	279
Repayment of Debt	-1,024	-1,700	-2,941	-1,375	-1,833	-1,447	-2,328	-1,651	-2,364	-1,460
Repurchase of Common Equity	-5.10	-9.30	-258	-129	-53	-3.10	-398	-255	-137	-15
Payment of Dividends	-151	-149	-166	-143	-411	-125	-120	-128	-117	-111
Issuance of Debt	649	1,336	3,617	2,143	1,673	1,056	2,987	1,449	2,469	1,836
Other Financing Activities, net	3.80	2.30	3.30	-2.30	18	21	11	269	21	29
Other Net Changes in Cash	0.50	-0.10	-	0.60	0.00	-	-	1.60	-	-

This table details how cash moves in and out of Scotts Miracle-Gro's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/30/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	7.10	-62	-208	215	55	-22	4.50	2.40	-0.60	-61	59
Net Cash From Operating Activities	188	-445	119	588	304	-343	535	563	-135	-432	551
Net Cash From Continuing Operating Activities	188	-445	119	588	304	-343	535	563	-135	-432	551
Net Income / (Loss) Continuing Operations	218	-70	-244	132	158	-81	-468	44	109	-65	-220
Consolidated Net Income / (Loss)	218	-70	-244	132	158	-81	-468	44	109	-65	-220
Depreciation Expense	16	16	16	17	16	16	18	16	16	18	18
Amortization Expense	3.20	3.10	3.90	3.90	3.90	4.00	4.40	6.70	6.40	7.70	8.60
Non-Cash Adjustments To Reconcile Net Income	32	38	154	-1.10	41	39	359	-22	85	36	45
Changes in Operating Assets and Liabilities, net	-80	-433	188	437	86	-322	622	519	-352	-428	699
Net Cash From Investing Activities	-11	-23	-20	-8.90	-18	-53	-21	-24	15	-36	51
Net Cash From Continuing Investing Activities	-11	-23	-20	-8.90	-18	-53	-21	-24	15	-36	51
Purchase of Property, Plant & Equipment	-8.30	-29	-17	-13	-16	-38	-19	-22	-22	-30	-15
Other Investing Activities, net	-3.10	6.00	-6.20	4.30	-1.60	6.10	32	-2.00	0.60	-6.40	12
Net Cash From Financing Activities	-170	408	-307	-364	-231	374	-509	-536	119	406	-543
Net Cash From Continuing Financing Activities	-170	408	-307	-364	-231	374	-509	-536	119	406	-543
Repayment of Debt	-254	-63	-271	-456	-266	-31	-512	-600	-385	-203	-684
Repurchase of Common Equity	-2.70	-16	-0.10	-0.10	-1.80	-3.10	-	-2.90	-5.60	-0.80	-0.20
Payment of Dividends	-39	-39	-38	-38	-39	-37	-37	-37	-38	-37	-37
Issuance of Debt	117	525	-	129	74	445	40	103	548	646	177
Other Financing Activities, net	9.30	0.70	1.40	0.70	1.20	0.50	0.60	0.50	0.60	0.60	0.70
Effect of Exchange Rate Changes	0.20	-0.90	-	-0.40	-0.20	-	-	0.10	0.20	0.20	-0.30

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015
Total Assets	2,872	3,414	4,297	4,800	3,381	3,029	3,055	2,747	2,756	2,527
Total Current Assets	980	1,398	1,982	2,024	1,217	1,042	886	882	1,033	1,119
Cash & Equivalents	72	32	87	244	17	19	34	121	29	71
Accounts Receivable	177	304	379	483	475	224	226	198	127	158
Inventories, net	588	880	1,344	1,127	622	540	481	408	395	396
Prepaid Expenses	145	181	173	170	81	174	60	67	52	121
Plant, Property, & Equipment, net	610	610	606	622	0.00	546	531	468	445	444
Total Noncurrent Assets	1,282	1,406	1,709	2,154	2,164	1,441	1,638	1,398	1,278	964
Long-Term Investments	45	92	194	207	0.00	-	36	31	101	0.00
Goodwill	244	244	254	605	544	539	543	442	372	284
Intangible Assets	419	437	580	710	679	708	857	749	690	655
Other Noncurrent Operating Assets	574	633	681	632	941	195	202	176	115	25
Total Liabilities & Shareholders' Equity	2,872	3,414	4,297	4,800	3,381	3,029	3,055	2,747	2,756	2,527
Total Liabilities	3,263	3,681	4,149	3,787	2,678	2,306	2,695	2,085	2,022	1,894
Total Current Liabilities	750	774	964	1,140	950	621	613	545	707	619
Short-Term Debt	53	52	144	58	66	128	133	143	185	133
Accounts Payable	255	271	423	609	391	214	151	153	131	193
Other Current Liabilities	443	450	397	473	493	278	330	248	178	251
Total Noncurrent Liabilities	2,512	2,907	3,185	2,646	1,727	1,685	2,082	1,541	1,314	1,276
Long-Term Debt	2,174	2,557	2,826	2,237	1,455	1,524	1,884	1,258	1,031	1,025
Other Noncurrent Operating Liabilities	338	350	359	410	272	162	198	283	284	251
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-391	-267	148	1,013	703	723	360	662	734	633
Total Preferred & Common Equity	-391	-267	148	1,013	697	719	355	649	715	621
Total Common Equity	-391	-267	148	1,013	697	719	355	649	715	621
Common Stock	362	353	364	477	483	442	420	408	402	400
Retained Earnings	304	491	1,020	1,605	1,236	1,275	920	978	882	684
Treasury Stock	-949	-999	-1,092	-1,002	-922	-904	-940	-668	-451	-357
Accumulated Other Comprehensive Income / (Loss)	-107	-113	-145	-66	-99	-94	-46	-69	-117	-107

This table presents Scotts Miracle-Gro's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	12/28/2024	6/29/2024	3/30/2024	12/30/2023	7/1/2023	4/1/2023	12/31/2022	7/2/2022
Total Assets	3,537	3,170	3,489	3,924	3,716	4,454	4,988	4,534	4,994
Total Current Assets	1,729	1,285	1,538	1,935	1,681	2,251	2,842	2,299	2,589
Cash & Equivalents	17	9.80	280	65	10	27	25	26	28
Accounts Receivable	799	214	505	877	288	1,160	1,458	490	953
Inventories, net	773	910	607	824	1,170	885	1,128	1,526	1,408
Prepaid Expenses	139	152	147	169	214	179	232	258	201
Plant, Property, & Equipment, net	603	607	599	608	610	590	589	593	625
Total Noncurrent Assets	1,206	1,278	1,352	1,381	1,424	1,613	1,557	1,642	1,780
Long-Term Investments	41	46	107	84	91	197	174	182	208
Goodwill	244	244	244	244	244	255	254	254	255
Intangible Assets	412	415	425	429	433	560	566	576	627
Other Noncurrent Operating Assets	509	573	576	624	656	602	563	630	690
Total Liabilities & Shareholders' Equity	3,537	3,170	3,489	3,924	3,716	4,454	4,988	4,534	4,994
Total Liabilities	3,827	3,650	3,636	4,175	4,102	4,320	4,851	4,475	4,576
Total Current Liabilities	1,013	684	854	1,060	764	1,329	1,373	932	1,072
Short-Term Debt	55	55	53	58	55	451	435	217	322
Accounts Payable	396	309	317	440	333	366	416	367	291
Other Current Liabilities	562	320	485	562	377	513	522	348	459
Total Noncurrent Liabilities	2,814	2,966	2,781	3,115	3,337	2,991	3,478	3,543	3,504
Long-Term Debt	2,493	2,637	2,436	2,761	2,969	2,629	3,138	3,190	3,156
Other Noncurrent Operating Liabilities	321	329	345	354	368	362	340	353	348
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-290	-480	-146	-251	-385	135	138	60	418
Total Preferred & Common Equity	-290	-480	-146	-251	-385	135	138	60	418
Total Common Equity	-290	-480	-146	-251	-385	135	138	60	418
Common Stock	343	349	361	354	350	351	374	368	362
Retained Earnings	374	196	586	492	372	997	990	918	1,277
Treasury Stock	-898	-920	-976	-978	-986	-1,032	-1,040	-1,057	-1,096
Accumulated Other Comprehensive Income / (Loss)	-109	-105	-117	-119	-122	-181	-187	-169	-125

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.04%	-9.50%	-20.32%	19.20%	30.91%	18.50%	0.81%	5.42%	5.70%	-8.04%
EBITDA Growth	447.92%	74.65%	-138.53%	19.34%	-9.02%	174.20%	-43.89%	-4.03%	61.43%	-7.27%
EBIT Growth	216.77%	59.24%	-157.59%	22.52%	-11.00%	244.88%	-53.05%	-6.17%	76.36%	-10.54%
NOPAT Growth	219.72%	59.82%	-155.00%	24.57%	44.18%	40.21%	-19.63%	-4.93%	80.17%	-12.88%
Net Income Growth	90.82%	13.12%	-185.22%	32.12%	-15.56%	622.45%	-70.89%	-30.50%	98.36%	-4.51%
EPS Growth	91.02%	13.83%	-187.95%	31.57%	-16.75%	630.36%	-69.15%	-28.68%	98.05%	-3.02%
Operating Cash Flow Growth	25.71%	511.63%	-147.51%	-51.34%	146.03%	-33.78%	-5.70%	48.85%	-1.17%	2.49%
Free Cash Flow Firm Growth	29.87%	274.54%	-194.93%	-116.32%	129.71%	246.80%	-226.11%	176.12%	142.28%	-265.76%
Invested Capital Growth	-22.50%	-21.81%	-0.67%	29.39%	-6.29%	2.17%	20.66%	7.53%	15.36%	22.06%
Revenue Q/Q Growth	1.14%	-3.24%	-5.86%	-3.00%	10.50%	2.06%	2.20%	13.02%	4.18%	-8.47%
EBITDA Q/Q Growth	225.20%	-170.10%	-133.43%	-6.72%	12.41%	13.75%	-26.83%	0.46%	4.64%	-4.86%
EBIT Q/Q Growth	4,319.57%	-988.27%	-77.59%	-7.29%	13.91%	15.90%	-34.79%	0.29%	5.27%	-6.83%
NOPAT Q/Q Growth	2,272.73%	-1,085.31%	-75.57%	-6.12%	12.09%	31.46%	-28.35%	1.11%	6.45%	-9.00%
Net Income Q/Q Growth	86.55%	-188.61%	-64.91%	-9.21%	19.09%	23.91%	-64.05%	-2.89%	-0.73%	-5.37%
EPS Q/Q Growth	87.10%	-186.50%	-63.83%	-9.22%	19.26%	23.19%	-64.44%	-3.46%	-1.17%	-4.10%
Operating Cash Flow Q/Q Growth	-38.44%	-2.80%	35.82%	-11.97%	60.81%	-15.44%	27.70%	-0.36%	25.90%	6.98%
Free Cash Flow Firm Q/Q Growth	-37.96%	-27.09%	64.74%	-140.04%	43.22%	-12.89%	43.67%	-53.24%	112.76%	-208.63%
Invested Capital Q/Q Growth	-12.11%	-25.81%	-22.46%	-5.57%	-17.56%	-12.60%	-16.36%	-10.67%	-17.99%	2.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.94%	18.51%	22.24%	29.83%	32.60%	32.31%	32.46%	36.81%	35.92%	34.20%
EBITDA Margin	7.99%	-2.30%	-8.20%	16.96%	16.94%	24.38%	10.54%	18.93%	20.79%	13.61%
Operating Margin	5.88%	-4.91%	-11.06%	14.68%	14.16%	12.98%	7.47%	16.40%	17.86%	10.70%
EBIT Margin	5.72%	-4.90%	-10.88%	15.06%	14.65%	21.55%	7.40%	15.90%	17.86%	10.70%
Profit (Net Income) Margin	-0.98%	-10.70%	-11.15%	10.42%	9.41%	14.58%	2.39%	8.28%	12.56%	6.69%
Tax Burden Percent	147.88%	83.85%	78.39%	75.82%	76.11%	79.13%	55.06%	69.48%	82.04%	77.41%
Interest Burden Percent	-11.61%	260.37%	130.67%	91.30%	84.35%	85.52%	58.67%	74.98%	85.72%	80.77%
Effective Tax Rate	0.00%	0.00%	0.00%	23.60%	24.23%	24.91%	-10.29%	37.03%	35.86%	37.22%
Return on Invested Capital (ROIC)	7.42%	-4.83%	-10.67%	21.81%	19.43%	13.19%	10.40%	14.80%	17.30%	11.37%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.46%	-14.80%	-16.57%	19.49%	15.94%	21.72%	0.66%	10.08%	20.15%	11.29%
Return on Net Nonoperating Assets (RNNOA)	3.19%	640.45%	-64.70%	38.02%	35.07%	71.81%	2.07%	16.55%	28.74%	15.07%
Return on Equity (ROE)	10.61%	635.62%	-75.37%	59.83%	54.50%	85.00%	12.47%	31.35%	46.04%	26.44%
Cash Return on Invested Capital (CROIC)	32.78%	19.66%	-10.00%	-3.81%	25.93%	11.05%	-8.32%	7.54%	3.04%	-8.50%
Operating Return on Assets (OROA)	6.47%	-4.52%	-9.39%	18.13%	18.89%	22.36%	6.80%	15.27%	16.94%	11.07%
Return on Assets (ROA)	-1.11%	-9.86%	-9.62%	12.55%	12.13%	15.13%	2.20%	7.95%	11.92%	6.92%
Return on Common Equity (ROCE)	10.61%	635.62%	-75.37%	59.63%	54.11%	84.26%	12.26%	30.63%	44.98%	25.87%
Return on Equity Simple (ROE_SIMPLE)	8.94%	142.20%	-296.21%	50.67%	55.74%	64.03%	17.96%	33.72%	44.02%	25.57%
Net Operating Profit after Tax (NOPAT)	146	-122	-304	552	443	308	219	273	287	159
NOPAT Margin	4.11%	-3.44%	-7.74%	11.22%	10.73%	9.75%	8.24%	10.33%	11.46%	6.72%
Net Nonoperating Expense Percent (NNEP)	7.88%	9.97%	5.90%	2.33%	3.49%	-8.53%	9.74%	4.72%	-2.84%	0.08%
Cost of Revenue to Revenue	76.06%	81.49%	77.76%	70.17%	67.40%	67.69%	67.54%	63.19%	64.08%	65.80%
SG&A Expenses to Revenue	15.73%	15.52%	15.62%	15.10%	18.34%	19.05%	20.28%	20.85%	20.67%	20.61%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.06%	23.42%	33.30%	15.15%	18.44%	19.33%	24.99%	20.41%	18.06%	23.49%
Earnings before Interest and Taxes (EBIT)	203	-174	-427	742	605	680	197	420	448	254
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	284	-82	-322	835	700	769	281	500	521	323
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	14.59	7.28	10.91	6.69	10.20	7.09	5.58	4.62
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.37	0.78	0.55	1.50	1.84	1.52	1.36	1.74	1.59	1.21
Price to Earnings (P/E)	0.00	0.00	0.00	14.40	19.63	10.43	56.78	21.06	12.66	17.95
Dividend Yield	3.07%	5.38%	6.79%	1.91%	1.73%	2.57%	3.28%	2.58%	2.90%	3.89%
Earnings Yield	0.00%	0.00%	0.00%	6.94%	5.10%	9.58%	1.76%	4.75%	7.90%	5.57%
Enterprise Value to Invested Capital (EV/IC)	4.07	2.36	1.71	3.23	4.13	2.74	2.41	3.07	2.87	2.57
Enterprise Value to Revenue (EV/Rev)	1.97	1.48	1.23	1.87	2.21	2.04	2.09	2.22	2.03	1.67
Enterprise Value to EBITDA (EV/EBITDA)	24.64	0.00	0.00	11.04	13.02	8.38	19.84	11.72	9.78	12.29
Enterprise Value to EBIT (EV/EBIT)	34.40	0.00	0.00	12.44	15.06	9.48	28.24	13.95	11.39	15.63
Enterprise Value to NOPAT (EV/NOPAT)	47.85	0.00	0.00	16.70	20.55	20.95	25.38	21.47	17.75	24.90
Enterprise Value to Operating Cash Flow (EV/OCF)	10.48	9.87	0.00	33.97	16.33	28.41	16.26	16.13	20.89	16.07
Enterprise Value to Free Cash Flow (EV/FCFF)	10.84	10.55	0.00	0.00	15.40	25.02	0.00	42.12	101.14	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-5.70	-9.76	20.11	2.26	2.16	2.28	5.61	2.12	1.66	1.83
Long-Term Debt to Equity	-5.57	-9.57	19.13	2.21	2.07	2.11	5.24	1.90	1.40	1.62
Financial Leverage	-6.99	-43.28	3.90	1.95	2.20	3.31	3.13	1.64	1.43	1.34
Leverage Ratio	-9.55	-64.47	7.84	4.77	4.49	5.62	5.68	3.94	3.86	3.82
Compound Leverage Factor	1.11	-167.86	10.24	4.35	3.79	4.80	3.33	2.96	3.31	3.09
Debt to Total Capital	121.27%	111.41%	95.26%	69.37%	68.40%	69.55%	84.87%	67.92%	62.35%	64.65%
Short-Term Debt to Total Capital	2.86%	2.23%	4.63%	1.75%	2.99%	5.39%	5.58%	6.94%	9.49%	7.40%
Long-Term Debt to Total Capital	118.41%	109.18%	90.64%	67.62%	65.42%	64.15%	79.28%	60.99%	52.86%	57.24%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.26%	0.19%	0.21%	0.63%	0.98%	0.69%
Common Equity to Total Capital	-21.27%	-11.41%	4.74%	30.63%	31.34%	30.26%	14.92%	31.45%	36.67%	34.66%
Debt to EBITDA	7.84	-31.98	-9.23	2.75	2.17	2.15	7.19	2.80	2.33	3.59
Net Debt to EBITDA	7.43	-30.46	-8.36	2.21	2.15	2.12	6.94	2.50	2.08	3.36
Long-Term Debt to EBITDA	7.66	-31.34	-8.78	2.68	2.08	1.98	6.71	2.52	1.98	3.18
Debt to NOPAT	15.24	-21.38	-9.78	4.15	3.43	5.37	9.19	5.13	4.24	7.27
Net Debt to NOPAT	14.44	-20.36	-8.85	3.34	3.39	5.31	8.87	4.58	3.78	6.82
Long-Term Debt to NOPAT	14.88	-20.95	-9.30	4.05	3.28	4.95	8.59	4.61	3.59	6.43
Altman Z-Score	2.61	1.74	1.51	3.39	4.12	3.79	2.42	3.43	3.22	2.80
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.33%	0.72%	0.88%	1.75%	2.29%	2.30%	2.16%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.31	1.81	2.06	1.77	1.28	1.68	1.45	1.62	1.46	1.81
Quick Ratio	0.33	0.43	0.48	0.64	0.54	0.53	0.56	0.75	0.47	0.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	645	497	-285	-97	592	258	-175	139	50	-119
Operating Cash Flow to CapEx	818.01%	588.04%	-256.97%	254.45%	0.00%	562.78%	542.79%	568.39%	436.49%	439.32%
Free Cash Flow to Firm to Interest Expense	4.06	2.79	-2.41	-1.22	6.25	2.53	-2.03	1.83	0.70	-2.44
Operating Cash Flow to Interest Expense	4.20	2.98	-1.09	3.44	5.89	2.23	3.96	4.77	3.40	5.06
Operating Cash Flow Less CapEx to Interest Expense	3.69	2.47	-1.52	2.09	6.45	1.83	3.23	3.93	2.62	3.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.13	0.92	0.86	1.20	1.29	1.04	0.92	0.96	0.95	1.03
Accounts Receivable Turnover	14.77	10.40	9.10	10.28	11.83	14.03	12.57	16.27	17.61	12.42
Inventory Turnover	3.68	2.60	2.47	3.95	4.79	4.18	4.05	4.16	4.06	4.00
Fixed Asset Turnover	5.83	5.84	6.39	0.00	0.00	5.86	5.33	5.79	5.64	5.38
Accounts Payable Turnover	10.28	8.34	5.91	6.91	9.20	11.72	11.85	11.74	9.90	8.08
Days Sales Outstanding (DSO)	24.71	35.10	40.10	35.51	30.86	26.02	29.03	22.43	20.73	29.38
Days Inventory Outstanding (DIO)	99.13	140.24	147.74	92.33	76.17	87.28	90.18	87.69	89.84	91.34
Days Payable Outstanding (DPO)	35.52	43.75	61.73	52.83	39.66	31.15	30.80	31.08	36.85	45.20
Cash Conversion Cycle (CCC)	88.32	131.58	126.12	75.01	67.37	82.14	88.42	79.04	73.71	75.52
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,719	2,219	2,838	2,857	2,208	2,356	2,306	1,911	1,777	1,541
Invested Capital Turnover	1.80	1.40	1.38	1.94	1.81	1.35	1.26	1.43	1.51	1.69
Increase / (Decrease) in Invested Capital	-499	-619	-19	649	-148	50	395	134	237	279
Enterprise Value (EV)	6,994	5,242	4,846	9,224	9,114	6,444	5,568	5,859	5,096	3,967
Market Capitalization	4,884	2,756	2,156	7,380	7,603	4,807	3,617	4,597	3,991	2,869
Book Value per Share	($6.87)	($4.76)	$2.67	$18.16	$12.50	$12.95	$6.40	$11.11	$11.80	$10.13
Tangible Book Value per Share	($18.54)	($16.88)	($12.39)	($5.40)	($9.43)	($9.51)	($18.86)	($9.27)	($5.72)	($5.19)
Total Capital	1,836	2,342	3,118	3,308	2,224	2,375	2,376	2,063	1,950	1,791
Total Debt	2,227	2,610	2,971	2,295	1,522	1,652	2,016	1,401	1,216	1,158
Total Long-Term Debt	2,174	2,557	2,826	2,237	1,455	1,524	1,884	1,258	1,031	1,025
Net Debt	2,110	2,486	2,690	1,843	1,505	1,633	1,946	1,250	1,086	1,086
Capital Expenditures (CapEx)	82	90	50	107	-53	40	63	64	56	56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	211	645	1,076	697	316	531	372	360	482	562
Debt-free Net Working Capital (DFNWC)	283	676	1,162	941	333	549	406	480	511	633
Net Working Capital (NWC)	230	624	1,018	884	266	421	273	337	326	501
Net Nonoperating Expense (NNE)	181	258	134	39	55	-153	156	54	-28	0.64
Net Nonoperating Obligations (NNO)	2,110	2,486	2,690	1,843	1,505	1,633	1,946	1,250	1,043	908
Total Depreciation and Amortization (D&A)	81	93	105	94	95	89	83	80	74	69
Debt-free, Cash-free Net Working Capital to Revenue	5.94%	18.15%	27.41%	14.16%	7.65%	16.81%	13.96%	13.62%	19.24%	23.69%
Debt-free Net Working Capital to Revenue	7.96%	19.05%	29.62%	19.11%	8.05%	17.40%	15.23%	18.18%	20.38%	26.70%
Net Working Capital to Revenue	6.48%	17.57%	25.94%	17.94%	6.44%	13.35%	10.25%	12.76%	13.00%	21.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.61)	($6.79)	($7.88)	$9.20	$6.96	$8.30	$1.13	$3.68	$5.16	$2.62
Adjusted Weighted Average Basic Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	55.33M	57.53M	60.09M	61.51M
Adjusted Diluted Earnings per Share	($0.61)	($6.79)	($7.88)	$8.96	$6.81	$8.18	$1.12	$3.63	$5.09	$2.57
Adjusted Weighted Average Diluted Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	55.33M	57.53M	60.09M	61.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.41M	56.55M	55.46M	55.16M	55.74M	55.82M	55.33M	57.53M	60.09M	61.51M
Normalized Net Operating Profit after Tax (NOPAT)	190	74	181	556	444	313	232	276	254	204
Normalized NOPAT Margin	5.35%	2.09%	4.62%	11.28%	10.75%	9.92%	8.70%	10.45%	10.14%	8.58%
Pre Tax Income Margin	-0.66%	-12.76%	-14.22%	13.75%	12.36%	18.43%	4.34%	11.92%	15.31%	8.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.28	-0.98	-3.62	9.40	6.39	6.68	2.28	5.52	6.24	5.20
NOPAT to Interest Expense	0.92	-0.69	-2.57	7.00	4.68	3.02	2.54	3.59	4.00	3.27
EBIT Less CapEx to Interest Expense	0.77	-1.48	-4.04	8.05	6.95	6.28	1.55	4.68	5.46	4.05
NOPAT Less CapEx to Interest Expense	0.41	-1.19	-3.00	5.65	5.24	2.63	1.81	2.75	3.22	2.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-433.52%	-39.23%	-37.99%	27.85%	105.82%	27.05%	188.38%	58.68%	37.04%	70.13%
Augmented Payout Ratio	-448.14%	-41.67%	-96.94%	53.04%	119.51%	27.73%	813.81%	175.32%	80.69%	79.46%

This table displays calculated financial ratios and metrics derived from Scotts Miracle-Gro's official financial filings.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/30/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.84%	1.56%	10.73%	7.46%	-0.40%	-22.07%	-24.13%	-5.68%	-8.75%	-6.96%	-33.11%
EBITDA Growth	24.54%	-15.97%	49.89%	120.08%	27.69%	-92.00%	-100.97%	118.66%	-45.30%	-72.41%	-1,520.66%
EBIT Growth	26.76%	-6.95%	47.74%	158.52%	31.89%	-21.64%	-87.06%	113.71%	-47.31%	-19.64%	-519.78%
NOPAT Growth	27.79%	-7.82%	48.07%	122.35%	29.48%	-13.16%	-85.76%	116.50%	-50.16%	-18.08%	-502.15%
Net Income Growth	38.10%	13.66%	47.92%	202.29%	43.97%	-24.42%	-112.86%	109.84%	-60.43%	-29.40%	-359.50%
EPS Growth	35.77%	14.79%	49.46%	196.10%	41.24%	-21.37%	-113.04%	109.61%	-60.73%	-30.00%	-365.48%
Operating Cash Flow Growth	-38.17%	-29.75%	-77.86%	4.51%	324.83%	20.48%	-2.78%	21.51%	64.16%	43.59%	15.04%
Free Cash Flow Firm Growth	-63.71%	-49.85%	6.16%	60.52%	6.17%	47.83%	338.00%	171.41%	219.91%	135.64%	79.60%
Invested Capital Growth	-9.03%	-15.02%	-22.50%	-34.58%	-31.13%	-22.15%	-21.81%	-18.29%	-23.23%	-13.19%	-0.67%
Revenue Q/Q Growth	240.93%	0.51%	-65.50%	-21.19%	271.69%	9.59%	-66.52%	-26.95%	190.83%	6.69%	-58.38%
EBITDA Q/Q Growth	1,185.03%	83.09%	-190.10%	-24.67%	1,110.42%	92.69%	-495.68%	-56.30%	1,619.33%	92.35%	63.26%
EBIT Q/Q Growth	756.60%	75.95%	-209.41%	-26.62%	653.99%	88.25%	-641.22%	-62.56%	610.95%	81.93%	60.32%
NOPAT Q/Q Growth	797.93%	76.40%	-204.73%	-25.92%	688.87%	88.63%	-548.37%	-56.86%	614.66%	81.34%	60.18%
Net Income Q/Q Growth	412.95%	71.52%	-284.71%	-16.13%	295.65%	82.82%	-1,172.08%	-60.05%	269.09%	70.60%	50.42%
EPS Q/Q Growth	407.44%	71.26%	-284.65%	-16.79%	292.96%	82.95%	-1,181.82%	-60.31%	265.81%	70.08%	51.19%
Operating Cash Flow Q/Q Growth	142.24%	-475.78%	-79.85%	93.29%	188.64%	-164.11%	-4.85%	515.82%	68.65%	-178.39%	18.92%
Free Cash Flow Firm Q/Q Growth	35.34%	-0.73%	-70.48%	-8.52%	87.02%	110.17%	-55.36%	-39.49%	160.40%	438.37%	86.61%
Invested Capital Q/Q Growth	2.06%	25.38%	-12.11%	-19.11%	-4.67%	14.35%	-25.81%	-14.84%	7.76%	14.84%	-22.46%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.56%	22.74%	-7.11%	29.45%	30.40%	15.16%	-15.22%	18.41%	26.95%	18.17%	-14.34%
EBITDA Margin	25.50%	-8.01%	-47.62%	18.23%	19.08%	-7.02%	-105.23%	8.90%	14.88%	-2.85%	-39.73%
Operating Margin	24.26%	-12.24%	-52.11%	16.64%	17.84%	-11.53%	-111.11%	6.91%	13.46%	-7.94%	-45.38%
EBIT Margin	24.17%	-12.55%	-52.45%	16.54%	17.76%	-11.92%	-111.13%	6.87%	13.41%	-7.63%	-45.08%
Profit (Net Income) Margin	15.31%	-16.67%	-58.84%	10.99%	10.33%	-19.62%	-125.10%	3.91%	7.14%	-12.29%	-44.59%
Tax Burden Percent	72.28%	72.47%	78.16%	72.19%	71.66%	70.49%	83.54%	84.04%	73.03%	68.61%	81.01%
Interest Burden Percent	87.62%	183.37%	143.54%	92.05%	81.14%	233.54%	134.74%	67.62%	72.93%	234.58%	122.11%
Effective Tax Rate	27.72%	0.00%	0.00%	27.81%	28.34%	0.00%	0.00%	15.96%	26.97%	0.00%	0.00%
Return on Invested Capital (ROIC)	26.23%	-12.99%	-65.82%	17.06%	14.78%	-9.56%	-109.25%	6.41%	9.09%	-6.16%	-43.78%
ROIC Less NNEP Spread (ROIC-NNEP)	25.00%	-14.21%	-69.85%	16.56%	13.54%	-11.11%	-116.10%	5.71%	7.91%	-7.31%	-46.58%
Return on Net Nonoperating Assets (RNNOA)	-238.46%	91.30%	487.96%	-7,204.46%	-721.69%	208.72%	5,024.44%	63.00%	49.58%	-50.24%	-181.86%
Return on Equity (ROE)	-212.23%	78.31%	422.15%	-7,187.39%	-706.91%	199.16%	4,915.18%	69.41%	58.67%	-56.40%	-225.64%
Cash Return on Invested Capital (CROIC)	15.18%	22.36%	32.78%	42.05%	34.18%	20.57%	19.66%	20.50%	15.51%	5.33%	-10.00%
Operating Return on Assets (OROA)	22.38%	-12.97%	-59.29%	14.62%	13.67%	-9.92%	-102.37%	5.34%	8.96%	-6.07%	-38.89%
Return on Assets (ROA)	14.17%	-17.24%	-66.51%	9.72%	7.95%	-16.33%	-115.24%	3.04%	4.77%	-9.76%	-38.47%
Return on Common Equity (ROCE)	-212.23%	78.31%	422.15%	-7,187.39%	-706.91%	199.16%	4,915.18%	69.41%	58.67%	-56.40%	-225.64%
Return on Equity Simple (ROE_SIMPLE)	-12.44%	4.98%	0.00%	177.43%	138.62%	102.72%	0.00%	-97.70%	-450.40%	-760.00%	0.00%
Net Operating Profit after Tax (NOPAT)	249	-36	-151	144	195	-33	-291	65	151	-29	-157
NOPAT Margin	17.53%	-8.57%	-36.48%	12.02%	12.78%	-8.07%	-77.78%	5.81%	9.83%	-5.56%	-31.77%
Net Nonoperating Expense Percent (NNEP)	1.23%	1.22%	4.04%	0.50%	1.24%	1.55%	6.85%	0.70%	1.18%	1.16%	2.79%
Return On Investment Capital (ROIC_SIMPLE)	11.04%	-1.61%	-	-	-	-1.26%	-	-	-	-	-
Cost of Revenue to Revenue	61.44%	77.26%	107.11%	70.55%	69.60%	84.84%	115.22%	81.59%	73.05%	81.83%	114.34%
SG&A Expenses to Revenue	13.25%	29.94%	28.36%	12.30%	11.72%	27.97%	28.84%	11.49%	12.16%	24.40%	23.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.30%	34.98%	45.00%	12.81%	12.56%	26.68%	95.89%	11.50%	13.48%	26.11%	31.04%
Earnings before Interest and Taxes (EBIT)	343	-52	-218	199	271	-49	-416	77	205	-40	-223
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	362	-33	-198	219	291	-29	-394	100	228	-15	-196
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.90	26.83	42.47	14.59
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.91	1.07	1.37	1.05	1.22	1.00	0.78	0.91	0.99	0.65	0.55
Price to Earnings (P/E)	87.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	4.82%	4.00%	3.07%	4.06%	3.57%	4.31%	5.38%	4.41%	4.00%	5.79%	6.79%
Earnings Yield	1.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.56	2.98	4.07	2.96	2.83	2.51	2.36	2.08	2.01	1.76	1.71
Enterprise Value to Revenue (EV/Rev)	1.63	1.81	1.97	1.65	2.00	1.85	1.48	1.69	1.89	1.47	1.23
Enterprise Value to EBITDA (EV/EBITDA)	16.08	23.01	24.64	66.41	0.00	0.00	0.00	53.36	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	20.70	32.15	34.40	1,260.42	0.00	0.00	0.00	316.92	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	42.63	44.76	47.85	941.23	0.00	0.00	0.00	501.34	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.55	11.37	10.48	5.35	6.47	10.27	9.87	11.37	15.81	28.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	16.08	12.25	10.84	5.57	6.77	10.68	10.55	9.11	11.26	30.64	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-8.78	-5.61	-5.70	-17.03	-11.23	-7.85	-9.76	22.85	25.99	57.25	20.11
Long-Term Debt to Equity	-8.59	-5.50	-5.57	-16.66	-11.00	-7.70	-9.57	19.50	22.82	53.61	19.13
Financial Leverage	-9.54	-6.43	-6.99	-434.93	-53.29	-18.78	-43.28	11.03	6.27	6.87	3.90
Leverage Ratio	-13.79	-7.96	-9.55	-696.82	-78.59	-25.31	-64.47	17.09	10.06	10.97	7.84
Compound Leverage Factor	-12.08	-14.60	-13.71	-641.44	-63.77	-59.12	-86.87	11.56	7.34	25.74	9.57
Debt to Total Capital	112.85%	121.68%	121.27%	106.24%	109.77%	114.61%	111.41%	95.81%	96.29%	98.28%	95.26%
Short-Term Debt to Total Capital	2.42%	2.47%	2.86%	2.26%	2.25%	2.07%	2.23%	14.02%	11.73%	6.26%	4.63%
Long-Term Debt to Total Capital	110.43%	119.21%	118.41%	103.98%	107.52%	112.54%	109.18%	81.78%	84.56%	92.03%	90.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-12.85%	-21.68%	-21.27%	-6.24%	-9.77%	-14.61%	-11.41%	4.19%	3.71%	1.72%	4.74%
Debt to EBITDA	7.26	9.64	7.84	28.51	-87.25	-31.69	-31.98	26.46	-6.91	-10.38	-9.23
Net Debt to EBITDA	7.10	9.44	7.43	24.08	-82.64	-30.63	-30.46	24.53	-6.53	-9.75	-8.36
Long-Term Debt to EBITDA	7.11	9.44	7.66	27.91	-85.46	-31.12	-31.34	22.58	-6.07	-9.72	-8.78
Debt to NOPAT	19.26	18.75	15.24	404.11	-35.32	-24.01	-21.38	248.55	-8.21	-11.05	-9.78
Net Debt to NOPAT	18.83	18.36	14.44	341.33	-33.45	-23.21	-20.36	230.48	-7.75	-10.38	-8.85
Long-Term Debt to NOPAT	18.85	18.37	14.88	395.52	-34.59	-23.58	-20.95	212.17	-7.21	-10.35	-9.30
Altman Z-Score	2.18	2.01	2.13	2.27	2.15	1.82	1.51	1.91	1.97	1.81	1.67
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.71	1.88	1.31	1.80	1.83	2.20	1.81	1.69	2.07	2.47	2.06
Quick Ratio	0.81	0.33	0.33	0.92	0.89	0.39	0.43	0.89	1.08	0.55	0.48
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	467	345	348	1,178	1,288	689	328	734	1,213	466	-138
Operating Cash Flow to CapEx	2,266.27%	-1,519.80%	713.86%	4,454.55%	1,866.26%	-905.54%	2,817.37%	2,557.27%	-609.46%	-1,458.11%	0.00%
Free Cash Flow to Firm to Interest Expense	12.77	10.25	10.51	30.37	29.21	16.09	8.19	15.59	25.12	10.91	-3.93
Operating Cash Flow to Interest Expense	5.14	-13.21	3.58	15.15	6.90	-8.02	13.38	11.94	-2.80	-10.11	15.73
Operating Cash Flow Less CapEx to Interest Expense	4.91	-14.08	3.08	14.81	6.53	-8.90	12.91	11.48	-3.26	-10.80	16.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	1.03	1.13	0.88	0.77	0.83	0.92	0.78	0.67	0.79	0.86
Accounts Receivable Turnover	4.12	14.20	14.77	4.22	2.94	8.83	10.40	3.48	2.58	9.70	9.10
Inventory Turnover	3.11	2.57	3.68	3.61	2.82	2.09	2.60	2.64	2.25	1.91	2.47
Fixed Asset Turnover	5.71	5.85	5.83	5.91	5.73	5.71	5.84	6.04	6.18	6.43	6.39
Accounts Payable Turnover	5.95	8.34	10.28	7.88	6.44	8.04	8.34	9.22	6.64	7.64	5.91
Days Sales Outstanding (DSO)	88.55	25.70	24.71	86.48	124.26	41.33	35.10	105.03	141.23	37.64	40.10
Days Inventory Outstanding (DIO)	117.21	141.81	99.13	101.22	129.34	174.98	140.24	138.22	162.13	191.42	147.74
Days Payable Outstanding (DPO)	61.39	43.77	35.52	46.31	56.71	45.40	43.75	39.59	54.98	47.78	61.73
Cash Conversion Cycle (CCC)	144.37	123.74	88.32	141.40	196.89	170.91	131.58	203.66	248.38	181.28	126.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,200	2,156	1,719	1,956	2,419	2,537	2,219	2,990	3,512	3,259	2,838
Invested Capital Turnover	1.50	1.52	1.80	1.42	1.16	1.19	1.40	1.10	0.92	1.11	1.38
Increase / (Decrease) in Invested Capital	-218	-381	-499	-1,034	-1,093	-722	-619	-669	-1,063	-495	-19
Enterprise Value (EV)	5,638	6,426	6,994	5,798	6,856	6,363	5,242	6,212	7,063	5,727	4,846
Market Capitalization	3,147	3,791	4,884	3,695	4,187	3,441	2,756	3,356	3,689	2,527	2,156
Book Value per Share	($5.05)	($8.35)	($6.87)	($2.57)	($4.43)	($6.80)	($4.76)	$2.40	$2.46	$1.07	$2.67
Tangible Book Value per Share	($16.46)	($19.83)	($18.54)	($14.35)	($16.29)	($18.74)	($16.88)	($12.13)	($12.19)	($13.90)	($12.39)
Total Capital	2,258	2,212	1,836	2,343	2,567	2,638	2,342	3,214	3,711	3,466	3,118
Total Debt	2,548	2,692	2,227	2,489	2,818	3,024	2,610	3,080	3,573	3,406	2,971
Total Long-Term Debt	2,493	2,637	2,174	2,436	2,761	2,969	2,557	2,629	3,138	3,190	2,826
Net Debt	2,490	2,635	2,110	2,103	2,669	2,922	2,486	2,856	3,374	3,199	2,690
Capital Expenditures (CapEx)	8.30	29	17	13	16	38	19	22	22	30	-39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	754	646	211	457	868	961	645	1,345	1,880	1,559	1,076
Debt-free Net Working Capital (DFNWC)	771	656	283	737	933	972	676	1,373	1,905	1,584	1,162
Net Working Capital (NWC)	716	602	230	684	875	917	624	922	1,470	1,368	1,018
Net Nonoperating Expense (NNE)	32	34	93	12	37	47	177	21	41	35	63
Net Nonoperating Obligations (NNO)	2,490	2,635	2,110	2,103	2,669	2,922	2,486	2,856	3,374	3,199	2,690
Total Depreciation and Amortization (D&A)	19	19	20	20	20	20	22	23	23	25	26
Debt-free, Cash-free Net Working Capital to Revenue	21.82%	18.16%	5.94%	13.01%	25.30%	27.99%	18.15%	36.65%	50.31%	40.13%	27.41%
Debt-free Net Working Capital to Revenue	22.31%	18.44%	7.96%	20.98%	27.20%	28.29%	19.05%	37.40%	50.97%	40.79%	29.62%
Net Working Capital to Revenue	20.73%	16.90%	6.48%	19.47%	25.51%	26.70%	17.57%	25.12%	39.33%	35.20%	25.94%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.78	($1.21)	($4.29)	$2.33	$2.77	($1.42)	($8.35)	$0.78	$1.95	($1.17)	($3.95)
Adjusted Weighted Average Basic Shares Outstanding	57.60M	57.30M	57.41M	56.80M	56.80M	56.70M	56.55M	56.20M	56M	55.50M	55.46M
Adjusted Diluted Earnings per Share	$3.72	($1.21)	($4.21)	$2.28	$2.74	($1.42)	($8.33)	$0.77	$1.94	($1.17)	($3.91)
Adjusted Weighted Average Diluted Shares Outstanding	58.40M	57.30M	57.41M	58M	57.40M	56.70M	56.55M	56.60M	56.50M	55.50M	55.46M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.72M	57.47M	57.41M	56.82M	56.80M	56.69M	56.55M	56.16M	56.07M	55.96M	55.46M
Normalized Net Operating Profit after Tax (NOPAT)	257	-24	-103	144	196	-38	-117	66	167	-23	-134
Normalized NOPAT Margin	18.08%	-5.79%	-24.90%	11.97%	12.88%	-9.28%	-31.33%	5.93%	10.87%	-4.43%	-27.12%
Pre Tax Income Margin	21.18%	-23.01%	-75.28%	15.22%	14.41%	-27.83%	-149.75%	4.65%	9.78%	-17.91%	-55.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.38	-1.55	-6.57	5.12	6.14	-1.14	-10.41	1.63	4.25	-0.94	-6.36
NOPAT to Interest Expense	6.81	-1.06	-4.57	3.72	4.42	-0.77	-7.28	1.38	3.12	-0.69	-4.48
EBIT Less CapEx to Interest Expense	9.16	-2.42	-7.07	4.78	5.77	-2.03	-10.88	1.17	3.79	-1.63	-5.23
NOPAT Less CapEx to Interest Expense	6.58	-1.93	-5.07	3.38	4.05	-1.66	-7.76	0.91	2.66	-1.38	-3.35
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	424.10%	-640.59%	-433.52%	-58.13%	-43.24%	-37.86%	-39.23%	-112.83%	-23.88%	-36.64%	-37.99%
Augmented Payout Ratio	475.35%	-714.23%	-448.14%	-60.06%	-45.49%	-40.79%	-41.67%	-120.05%	-25.16%	-65.21%	-96.94%

Frequently Asked Questions About Scotts Miracle-Gro's Financials

When does Scotts Miracle-Gro's financial year end?

According to the most recent income statement we have on file, Scotts Miracle-Gro's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Scotts Miracle-Gro's net income changed over the last 9 years?

Scotts Miracle-Gro's net income appears to be on a downward trend, with a most recent value of -$34.90 million in 2024, falling from $158.70 million in 2015. The previous period was -$380.10 million in 2023. Check out Scotts Miracle-Gro's forecast to explore projected trends and price targets.

What is Scotts Miracle-Gro's operating income?

Scotts Miracle-Gro's total operating income in 2024 was $208.80 million, based on the following breakdown:

Total Gross Profit: $850.50 million
Total Operating Expenses: $641.70 million

How has Scotts Miracle-Gro revenue changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's total revenue changed from $2.37 billion in 2015 to $3.55 billion in 2024, a change of 49.8%.

How much debt does Scotts Miracle-Gro have?

Scotts Miracle-Gro's total liabilities were at $3.26 billion at the end of 2024, a 11.4% decrease from 2023, and a 72.2% increase since 2015.

How much cash does Scotts Miracle-Gro have?

In the past 9 years, Scotts Miracle-Gro's cash and equivalents has ranged from $16.60 million in 2020 to $244.10 million in 2021, and is currently $71.60 million as of their latest financial filing in 2024.

How has Scotts Miracle-Gro's book value per share changed over the last 9 years?

Over the last 9 years, Scotts Miracle-Gro's book value per share changed from 10.13 in 2015 to -6.87 in 2024, a change of -167.8%.

Related Companies

This page (NYSE:SMG) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scotts Miracle-Gro (SMG) Financials

Frequently Asked Questions About Scotts Miracle-Gro's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Scotts Miracle-Gro (SMG) Financials

Annual Income Statements for Scotts Miracle-Gro

Quarterly Income Statements for Scotts Miracle-Gro

Annual Cash Flow Statements for Scotts Miracle-Gro

Quarterly Cash Flow Statements for Scotts Miracle-Gro

Annual Balance Sheets for Scotts Miracle-Gro

Quarterly Balance Sheets for Scotts Miracle-Gro

Annual Metrics And Ratios for Scotts Miracle-Gro

Quarterly Metrics And Ratios for Scotts Miracle-Gro

Frequently Asked Questions About Scotts Miracle-Gro's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools